首页> 外国专利> USE OF IL10 HAPLOTYPE FOR PREDICTING SUSCEPTIBILITY TO PROGRESSION OF HBV TO DEVELOPMENT OF HCC CONSEQUETNLY TO INHIBIT DEVELOPMENT OF HCC BY IMITATING OR INCREASING THE ACTIVITY OF IL-10(INTERLEUKIN-10)

USE OF IL10 HAPLOTYPE FOR PREDICTING SUSCEPTIBILITY TO PROGRESSION OF HBV TO DEVELOPMENT OF HCC CONSEQUETNLY TO INHIBIT DEVELOPMENT OF HCC BY IMITATING OR INCREASING THE ACTIVITY OF IL-10(INTERLEUKIN-10)

机译:使用IL10型来预测易感性或通过增加IL-10(interleukin-10)的活性来抑制HBV向HCC的发展,从而抑制HCC的发展

摘要

PURPOSE: Use of IL10 haplotype for predicting susceptibility to progression of HBV to development of HCC is provided. Therefore, the development of HCC(hepatocellular carcinoma) is effectively inhibited by imitating or increasing the activity of IL-10(interleukin-10). CONSTITUTION: A method for predicting susceptibility to progression of HBV or development of HCC is characterized by measuring IL10 haplotype which is dose-dependent on the progression of HBV or development of HCC, wherein the IL10 haplotype is IL-heterotype2(IL-ht2). The method for predicting susceptibility of progression of HBV or development of HCC comprises the steps of: collecting a DNA sample containing human IL10; and detecting IL10 haplotype which is dose-dependent on the progression of HBV or development of HCC using one or more of primers having the nucleotide sequence selected from SEQ ID NO:1 to SEQ ID NO:12. A kit for predicting susceptibility of progression of HBV or development of HCC comprises probes which specifically bind to an human IL10 haplotype sequence.
机译:目的:提供IL10单倍型用于预测HBV进展为HCC发展的易感性。因此,通过模仿或增加IL-10(白介素-10)的活性可有效抑制肝癌的发展。组成:一种预测HBV或HCC发展的易感性的方法的特征是通过测量IL10单倍型,其剂量依赖于HBV或HCC的发展,其中IL10单倍型是IL-异型2(IL-ht2)。预测HBV进展或HCC发展的易感性的方法包括以下步骤:收集含有人IL10的DNA样品。使用一种或多种具有选自SEQ ID NO:1至SEQ ID NO:12的核苷酸序列的引物检测IL10单倍型,该IL10单倍型取决于HBV的进展或HCC的发展。预测HBV进展或HCC发生的易感性的试剂盒包含与人IL10单倍型序列特异性结合的探针。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号